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Summary 
The main objective of this thesis was to investigate the carcinogenic potential of the three 
toxicants Perfluorooctane sulfonate (PFOS), Perfluorononanoic acid (PFNA) and Tetra-
bromobispehenol-A (TBBPA), using the Syrian Hamster Embryo (SHE) Cell Transformation 
assay (CTA). The SHE CTA is an in vitro assay based on the morphological change of cell 
colonies when exposed to carcinogenic compounds. The cells used were primary cells isolated 
from Syrian hamster embryos. The SHE CTA has been used for several decades (Rivedal 
1982), and the Organization for Economic Co-operation (OECD) has recently performed a 
prevalidation study and made a recommended protocol with a photo catalogue to help the 
scoring of the transformed colonies (Maire et al. 2012a; Maire et al. 2012b). Concentrations 
between 0.1 nM and 550 µM were tested in the current study, based on a dose range-finding 
experiment for each of the chemicals. 
In addition to the SHE CTA, the DCF assay was used to investigate if exposure to PFOS, 
Perfluorooctanic acid (PFOA), PFNA and TBBPA would increase the production of reactive 
oxygen species (ROS) in SHE cells. This was tested to investigate if increased ROS 
production could be one of the mechanisms behind potential carcinogenicity of the 
compounds. In the experiments with the perfluorinated compounds concentrations between 1 
µM and 1 mM were tested. In the experiment with TBBPA concentrations between 10 nM 
and 1 mM were tested. 
The SHE CTA of PFOS did not give a valid answer, because of too low transformation 
frequency in the positive control Benzo-a-Pyrene (B[a]P). PFNA gave an inconclusive result, 
with only one concentration significantly different from the negative control Dimethyl 
sulfoxide (DMSO) in the experiments. TBBPA on the other hand gave a positive response in 
the SHE CTA with two positive concentrations, and it is therefore possible to say that TBBPA 
causes transformation in SHE cells. On the basis of the DCF assay experiments, it is unlikely 
that increase in ROS production is a part of the mechanisms behind these perfluorinated 
compounds’ cytotoxic and carcinogenic potential. It was not possible to detect if TBBPA 
caused an increase in ROS production based on the assay used in this thesis.  
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Sammendrag 
Hensikten med denne studien var å undersøke de tre kjemikaliene Perfluorooctane sulfonate 
(PFOS), Perfluorononanoic acid (PFNA) og Tetrabromobispehenol-A (TBBPA) sitt 
karsinogene potensiale. Dette ble gjort ved å utføre Syriskhamsterembryo (SHE) 
celletransformasjonsanalyse (CTA). Dette er en in vitro analyse basert på endring i 
cellekoloniers morfologi etter eksponering av karsinogene stoffer. Cellene benyttet er 
primærceller, isolert fra 13 dager gamle Syriske hamsterembryoer. Denne analysen har blitt 
benyttet i flere tiår og Organization for Economic Co-operation (OECD) har gjort en pre-
valideringsstudie og lagd en anbefalt protokoll, samt en fotoguide for å hjelpe med scoringen 
av transformerte kolonier. Konsentrasjoner mellom 0,1 nM og 550 µM ble testet av de ulike 
kjemikaliene, basert på doseområde tester utført for hvert enkelt kjemikalie. 
I tillegg til analysen av SHE celle transformasjon ble det utført en DCF analyse. Dette ble 
gjort for å se om eksponering av SHE celler av PFOS, Perfluorooctanic acid (PFOA), PFNA 
og TBBPA ville øke produksjonen av reaktive oksidanter (ROS) i cellene. Dette ble gjort for 
å undersøke om økt ROS produksjon kunne være en grunn til eventuelt karsinogent 
potensiale. I eksperimentene med de perfluorerte stoffene ble konsentrasjoner mellom 1 µM 
og 1 mM undersøkt. I eksperimentet med TBBPA ble konsentrasjoner mellom 10 nM og 1 
mM testet. 
Resultatene fra analysen etter eksponering av SHE celler for PFOS kunne ikke gi et gyldig 
resultat, fordi det var for lav transformasjonsrate på den positive kontrollen Benzo-a-Pyrene 
(B[a]P). PFNA eksponeringen ga et usikkert resultat med bare en signifikant konsentrasjon i 
tillegg til den positive kontrollen. TBBPA ga derimot et positivt resultat i SHE CTA med to 
konsentrasjoner signifikant forskjellig fra den negative kontrollen Dimethyl sulfoxide 
(DMSO). På bakgrunn av DCF forsøkene ser det ikke ut til at de perfluorerte stoffene testet 
her gir økning i ROS produksjon i forhold til DMSO kontrollen. Det var ikke mulig å 
undersøke om TBBPA ga økning i ROS produksjon basert på testen benyttet i denne studien. 
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Abbreviations: 
 
°C:   Degrees Celsius 
µg:   Microgram 
µl:   Microliter 
µM:   Micromolar 
AUC:   Area under the curve 
BFR:    Brominated flame retardant 
B[a]P:   Benzo-a-Pyrene 
BP-A:   Bisphenol-A 
CMF-PBS:   Calcium-and magnesium-free phosphate buffered saline 
CO2:   Carbon dioxide 
CTA:    Cell transformation assay 
DDT:   Dichlorodiphenyltrichloroethane 
DCF:   2’,7’-dichlorofluorescin 
DCFH:  2’,7’-dichlorodihydrofluorescein 
DCFH-DA:  2’,7’-dichlorodihydrofluorescein diacetate 
DRF:    Dose range finding 
DMEM:   Dulbecco’s Modified Eagle’s Medium 
DMSO:   Dimethyl sulfoxide 
DNA:   Deoxyribonucleic acid 
EURL ECVAM:  European Union Reference Laboratory for alternatives to animal testing 
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FBS:    Fetal bovine serum 
H2O2:   Hydrogen Peroxide 
H295R cells:  Human adrenocortical carcinoma cells 
HBSS:   Hank’s Balanced Salt solution 
HepG2 cells:  Liver hepatocellular cells 
Klif:   Klima- og forurensningsdirektoratet 
MC:   Medium change 
ml:   Milliliter 
mM:   Millimolar 
MTF:    Morphological transformation frequency 
NaHCO3:  Sodium Bicarbonate 
ng:   Nanogram 
nM:   Nanomolar 
O2
˙-
:   Superoxide anion 
OECD:   Organization for Economic Co-operation 
·OH:   Hydroxyl radical 
PBDE:   Polybrominated diphenyl ether 
PCB:   Polychlorinated biphenyl 
PE:    Plating efficiency 
PFC:    Perfluorinated chemical 
PFNA:   Perfluorononanoic acid 
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PFOA:   Perfluorooctanic acid 
PFOS:   Perfluorooctane sulfonate 
POPs:    Persistent organic pollutants 
ROS:    Reactive oxygen species 
RPE:    Relative plating efficiency 
SHE:    Syrian hamster embryo 
TBBPA:  Tetrabromobispehenol-A 
TPA:   12-O-tetra-decanoyl-phorbol-13-acetat 
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1. Introduction 
 
1.1 Persistent organic pollutants 
Synthetic chemical compounds have been found in the environment and in humans. Many of 
the compounds are persistent organic pollutants (POPs). POPs are generally defined as 
persistent, organic substances, which bioaccumulate, possess toxic characteristics and cause 
significant adverse effects to human health or to the environment, both near to and distant 
from their sources (UN-ECE). POPs are prone to long-range transboundary atmospheric 
transport and deposition, and are therefore globally distributed. There have even been found 
POPs in the Arctic, where no such substances are produced (El-Shahawi et al. 2010). 
POPs may be released both intentionally and unintentionally. Unintentionally release of POPs 
may happen by volatilization or leakage, both during a products lifetime and after ultimate 
disposal, while pesticides, such as dichlorodiphenyltrichloroethane (DDT), are intentionally 
released at their point of application (Vallack et al. 1998). 
There is a global concern related to the effects of POPs. As a consequence, the Stockholm 
Convention on persistent organic pollutants was adopted in 2001. This requires countries to 
take necessary measures to reduce and in some cases eliminate the release of POPs into the 
environment. The aim is to protect human health and wildlife (UNEP). Because of the 
Stockholm convention several POPs, like Perfluorooctane sulfonate (PFOS) and DDT, are 
banned in most countries. However, some countries still use them, and because of their 
persistency and lipophilic character they will stay in the environment, and reach high 
concentrations in top predators in many decades to come (El-Shahawi et al. 2010). 
Animals on the top of the ecosystem, like polar bears and humans, are most prone to exposure 
to POPs, as these tends to bioaccumulate, and biomagnify up the food chain (Wania & 
Mackay 1999). POPs have shown to give adverse health problems such as birth defects, 
immunological, behavioral, neurological and reproductive discrepancies and cancer in 
humans (El-Shahawi et al. 2010). The main exposure source for humans is dietary intake of 
dairy products, meat and fish (Hardell et al. 2010). 
There are several groups of chemicals within the definition of POPs. These include among 
others polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), various 
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organochlorine pesticides such as DDT and perfluorinated compounds (PFCs) (Hardell et al. 
2010). In this thesis the focus will be on the PFCs. 
1.1.1 Perfluorinated compounds 
Perfluorinated compounds are synthetically produced fluorinated compounds composed of a 
carbon backbone. They are usually 4-14 atoms in length with a charged moiety, typically 
carboxylate or sulfonate. The carbon fluorine bond is extremely strong, and this makes the 
PFCs very resistant to degradation by heat, reactions with strong acids or bases, and oxidizing 
agents or photolysis (Florentin et al. 2011; Melvin E. Andersen et al. 2007).  
PFCs are used in a wide range of industrial products because of their anti-wetting and 
surfactant properties. Perfluorinated compounds have been extensively used in industry in 
products as pesticides, herbicides, refrigerants, anesthetics, lubricants and insecticides and in 
consumer products as surfactants, oil and water repellant coating for cookware, carpets or 
textiles (Eriksen et al. 2010; Florentin et al. 2011; Xiao-Zhong & De-Cong 2009). The 
distribution and degradation of PFCs in the environment is complex, and gives a complicated 
exposure pattern. Most scientists conclude that food is the major exposure pathway for 
humans, but the ingestion of dust can also be a potential source of PFC exposure (D'Hollander 
et al. 2010). 
Since the PFCs are very resistant to degradation they are found several places in the 
environment and wildlife. In this thesis I will focus on three PFCs; PFOS, PFOA and PFNA, 
which are the three PFCs with highest concentration found in human serum in Norway (Haug 
et al. 2010). 
1.1.2 Perfluorooctanesulfonic acid  
PFOS is the PFC found in highest concentration in human serum in the Norwegian population 
(Haug et al. 2010). PFOS has 8 carbon atoms and a sulfonic acid group at the end (Figure 1). 
Its half-life is of 5.4 years in humans (Olsen et al. 2007). PFOS has been widely used as a 
surfactant since the 1950s, but has recently been added to Annex B of the Stockholm 
Convention, because of its adverse health effects (Buck et al. 2011; Jacquet et al. 2012a). This 
has led to a reduction in PFOS levels in the environment (Calafat et al. 2007).  
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Figure 1: Chemical structure of PFOS (C8HF17O3S). 
PFOS is found to induce adverse health effects like cancer, hormone disruption, 
immunotoxicity and neonatal mortality (Yong et al. 2010). Exposure to 600 µM PFOS 
resulted in a dose responsive increase in oestradiol and a smaller increase in progesterone and 
testosterone secretion in the in vitro human adrenocortical carcinoma (H295R) cells 
(Kraugerud et al. 2011). 
PFOS is not mutagenic, but has shown to have carcinogenic potential in the Syrian hamster 
embryo (SHE) cell transformation assay (CTA). It has also shown to be carcinogenic in 
rodents. Chronic exposures to PFOS in rats have been associated with tumor development in 
the liver, pancreas and testis (Eriksen et al. 2010). Production of reactive oxygen species 
(ROS) has also been investigated after exposure to PFOS, but the results point in different 
directions (Florentin et al. 2011; Jacquet et al. 2012a). Florentin (2011) did not detect an 
increase in ROS production in liver hepatocellular (HepG2) cells after PFOS exposure, while 
Eriksen et al. (2010) found an increase in ROS production in HepG2 cells.  
1.1.3 Perfluorooctanoic acid 
 Perfluoroooctanoic acid (PFOA) is a PFC which consists of an 8 carbon-chain with a 
carboxylic acid group (Figure 2). It has a half-life of 3.8 years in humans (Olsen et al. 2007), 
and the concentration of PFOA in human serum is in Norway found to be 4.1 ng/ml (Haug et 
al. 2010). PFOA is used as a surfactant and has been used for many decades as an essential 
processing aid in the manufacture of fluoropolymers such as polytetrafluoroethylene (Buck et 
al. 2011). 
 
Figure 2: Chemical structure of PFOA (C8HF15O2). 
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Effects have been found on the liver but not on the kidneys in mice treated with PFOA in the 
drinking water. Altered transcription of genes related to cell communication, growth, 
apoptosis and fatty acid metabolisms in rats have also been detected after exposure to PFOA 
(Xiao-Zhong & De-Cong 2009). But only small changes in hormone secretion have been 
detected in H295R cells (Kraugerud et al. 2011). 
PFOA acts as a tumor promoter in Syrian hamster embryo cells and has been shown to be 
carcinogenic in rodents (Florentin et al. 2011; Jacquet et al. 2012b). Chronic exposures to 
PFOA have in rats been associated with tumor development in the liver, pancreas and testis 
(Eriksen et al. 2010). Eriksen et al. (2010) found that PFOA increased ROS production in 
HepG2 cells by 1.52-fold compared to unexposed cells. PFOA generated the most ROS 
compared with the other PFCs. However, Florentin et al. (2011) did not find an increase in 
ROS production after exposure to PFOA in HepG2 cells (Florentin et al. 2011).  
1.1.4 Perfluorononanoic acid 
Perfluorononanoic acid (PFNA) is also found in human serum in Norway (Haug et al. 2010). 
PFNA is a PFC with 9 carbon atoms and a carboxyl group at the end (Figure 3). It has been 
manufactured since 1975, principally for producing fluoropolymer dispersions, especially 
polyvinylidene fluoride (Buck et al. 2011).The half-life for PFNA in human serum has not 
been estimated yet (Nelson et al. 2010). In rats the half-life for PFNA is longer than for PFOA 
(Ohmori et al. 2003). Since most countries have stopped producing PFOS, its concentration 
has declined in the environment, and the values found in humans and wildlife are decreasing. 
The amount of PFNA produced is on the other hand increasing (Lau et al. 2007). 
 
Figure 3: Chemical structure of PFNA (C9HF17O2). 
In the H295R in vitro cell assay only small changes in hormone secretion were detected after 
exposure to PFNA (Kraugerud et al. 2011). Exposure to PFNA in human HepG2 cells also 
caused only a small increase in DNA damage at cytotoxic concentration levels (Eriksen et al. 
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2010). In addition it has been discovered that PFNA can have endocrine disruptive effects in 
rodent models and in in vitro systems (Kraugerud et al. 2011). 
Eriksen et al. found that the production of ROS after exposure to PFNA had an insignificant 
increase in the human HepG2 cells, except at 1 and 2 mM where the production was 
decreased (Eriksen et al. 2010). To the best of my knowledge there have not yet been done 
any experiments to test if PFNA is carcinogenic without being mutagenic. 
 
1.2 Brominated flame retardants 
Brominated flame retardants (BFRs) are brominated compounds incorporated into plastic 
products and polymers to reduce flammability (Alaee et al. 2003). They can be used in 
products such as electronic equipment, textiles and isolation material. BFRs can be released 
into the environment with effluents from factories producing BFRs and plastic products. 
Other ways BFRs may be released to the environment are from hazardous waste, facilities 
recycling plastics, metals from electronic devices and accidental fires (Watanabe & Sakai 
2003). 
BFRs, such as PBDEs and TBBPA have been found in human milk and the blood of the 
general population (Watanabe & Sakai 2003). Some BFRs have serious health effects, such as 
thyrodigenic, estrogenic, and dioxin-like activities (Watanabe & Sakai 2003). 
Research has also shown that some BFRs have effects on the thyroid gland, the liver and the 
kidneys. Effects on behavioral development have also been detected (Darnerud 2003). One of 
the main routes of exposure of the general human population to BFRs such as for example 
PBDEs, particularly the lower brominated congeners, is through the diet, as is the case with 
PCBs and PCDDs/DFs. But for less persistent BFRs, inhalation of air polluted by these 
compounds is the main exposure pathway. People may also be exposed in the work 
environment where dismantling of electronic components, shredding and smelting of 
electronic components take place (Watanabe & Sakai 2003).  
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1.2.1 Tetrabromobisphenol-A  
Tetrabromobisphenol-A (TBBPA) is a brominated flame retardant produced via bromination 
of bisphenol-A (BP-A) (Figure 4) (Alaee et al. 2003). It is one of the most frequently used 
BFRs (Reistad et al. 2005). TPPBA is a phenolic, weakly acidic and hydrophobic compound, 
and is as BFRs usually are, reactive, which means that it binds covalently to the material it is 
supposed to protect. Some of the reactive BFRs may not polymerize and can be released to 
the environment (de Wit 2002). TBBPA has a half-life of two days and can thus not go under 
the characterization persistent organic pollutant. Non persistent BFRs such as TBBPA do not 
biomagnify, hence leading to direct exposures via inhalation being the most likely route of 
exposure (Sjodin et al. 2003). TBBPA has been found in river sediments in Sweden and Japan 
and in workers occupationally exposed to BFRs (Sjodin et al. 2003).  
 
Figure 4: Chemical structure of TBBPA. 
In experimental in vivo studies the toxicity of TBBPA is suggested to be low (Darnerud 
2003). But rainbow trout exhibited irritation, twitching, erratic swimming, dark discoloration 
and labored respiration when exposed to TBBPA (de Wit 2002). TBBPA fed orally to mice 
and rats showed low or no effects on behavior, weight gain, mortality, organ abnormalities or 
hematology (de Wit 2002). A key concern with TBBPA is that it has a similar chemical 
structure to thyroxine (T4), and it has been shown to bind competitively, with high affinity to 
human transthyretin in vitro (Alaee et al. 2003). TBBPA has not shown to be mutagenic in 
studies with Salmonella typhimurium strains (Darnerud 2003). As far as I know there have not 
been performed any experiments to test if TBBPA is carcinogenic without being mutagenic. 
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1.3 Syrian hamster embryo cell transformation assay as a model 
The SHE CTA was first developed by Berwald and Sachs in 1963 and 1964 respectively. The 
SHE CTA is one of several in vitro methods developed, which mimic some of the stages in 
cancer development (Vasseur & Lasne 2012). In risk assessment of chemical compounds it is 
important to investigate the carcinogenic potential of the substances (Corvi et al. 2012). 
Today the most used method is a two year rodent assay, and there is a need to develop 
methods to test chemical carcinogenicity without the use of animals. The Organization for 
Economic Co-operation (OECD) has therefore performed a pre-validation study on the SHE 
CTA and developed a test guide to secure reproducible results between laboratories 
(Vanparys et al. 2011). 
SHE cells are isolated from 13 days old Syrian hamster embryos. They are primary cells and 
are therefore like “normal” cells, with a competent metabolic system and a finite lifespan, in 
contrast to cell lines, which are modified cells. SHE cells have a low spontaneous 
transformation rate and the transformation occurs within a few days of exposure. This makes 
this method much more time efficient than rodent assays which last for years. It is also much 
more cost efficient (Corvi et al. 2012; Maire et al. 2012a). The SHE CTA has shown to 
correspond 85% with rodent carcinogenic tests and is therefore a good method to investigate 
if a chemical should be studied further (Kamendulis et al. 2002). 
In vitro transformed cells exhibit morphological changes related to neoplasia in cancer 
development. The phenomenon of morphological cell transformation involves changes in 
behavior and growth control of cultured cells, such as alteration of cell morphology, 
disorganized pattern of colony growth, and acquisition of anchorage independent growth 
(Combes et al., 1999). Transformed cells have a lower cytoplasm to nucleus ratio compared to 
normal cells. They grow in criss-cross and can grow over feeder cells, whereas cells in normal 
colonies grow in a pattern, without stacking and tend avoid feeder cells. 
In vitro cell transformation is, to date, the only well-established methodology which has the 
potential to detect both genotoxic and non-genotoxic carcinogenic compounds (Adler et al. 
2011; Vanparys et al. 2011). The SHE CTA has been used to test several chemicals, among 
these PFOS, PFOA, Cyanide and BP-A have been demonstrated to be carcinogenic or to act 
as a tumor promoter in these cells (Jacquet et al. 2012a; Jacquet et al. 2012b; Kamendulis et 
al. 2002; Tsutsui et al. 1998). Many chemicals which can be carcinogenic can give negative 
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results in mutagenesis tests like Ames test and the mouse-lymphoma assay, whereas they may 
give positive results in the SHE CTA. The Mouse lymphoma assay detects mutagenic and 
clastogenic events at the thymidine kinase locus of L5178Y mouse lymphoma tk (+/-) cells. 
The Ames test also detects mutagenesis, but neither of these the tests detect non-genotoxic 
chemicals (Lloyd & Kidd 2012; Mortelmans & Zeiger 2000).  
 
1.4 Reactive oxygen species 
Reactive oxygen species are a group of short lived, oxygen containing, reactive molecules 
with one or more unpaired electrons (Alfadda & Sallam 2012; Yong et al. 2010). Examples 
are superoxide anion (O2·
-), hydrogen peroxide (H2O2), and hydroxyl radicals (·OH). ROS can 
be generated in many different organelles in the cell. The two organelles most intimately 
involved in their metabolism and production is the endoplasmic reticulum and the 
mitochondria (Liu et al. 2007). ROS can also be generated during irradiation by UV light, X-
rays and by gamma rays. In addition exposure to POPs such as PCBs can increase the amount 
of ROS production in the cell (Brieger et al. 2012; Myhre et al. 2009). 
ROS have several tasks in the body. They are linked to physiological processes and protective 
mechanisms, they can act as a second messenger in the cell, and have a role in immune 
defense and antibacterial action (Alfadda & Sallam 2012; Valko et al. 2006). ROS can also 
damage the cell. They can cause permanent structural changes in DNA, initiate lipid 
peroxidation and protein oxidation, and modulate activity of stress proteins and stress genes. 
In addition they can activate cytoplasmic and nuclear signal transduction pathways. ROS have 
also been thought to be involved in many diseases, including cardiovascular disorders, 
carcinogenesis, chronic inflammation, and neurodegenerative diseases (Yong et al. 2010). 
Insulin resistance, diabetes mellitus and atherosclerosis have also been linked to ROS 
production (Alfadda & Sallam 2012). ROS can lead to permanent modifications of genetic 
material associated with carcinogenesis. It induces damage involves single or double-stranded 
breaks, purine, pyrimidine, or deoxyribose modifications, and DNA cross-links. DNA damage 
can result either in arrest or induction of transcription, induction of signal transduction 
pathways, replication errors and genomic instability, which are all associated with cancer 
(Valko et al. 2006) . 
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1.5 Detection of reactive oxygen species 
There are several types of ROS, and different techniques are used to detect them. To do a 
complete investigation of ROS production in cells, a variety of methods should be used, since 
none can detect all the different types of ROS. One of the techniques that may be used is the 
2’,7’-dichlorofluorescein (DCF) assay.  
In the DCF assay the nonpolar, nonionic probe 2’,7’-dichlorodihydrofluorescein diacetate 
(DCFH-DA) diffuse into the cell through the cell membrane where it is hydrolyzed to 2’,7’-
dichlorodihydrofluorescein (DCFH) by intercellular esterase activity. DCFH is non-
fluorescent, but emits fluorescence when it is oxidized to DCF. The DCF assay detects the 
presence of various ROS, and is therefore often used as a general indicator of oxidative stress 
in cells (Wang & Joseph 1999). Some of the ROS the DCF assay is sensitive towards are 
ONOO
-
, H2O2 in combination with cellular peroxidases, peroxidases alone and ·OH. It is 
however not suitable for measurement of HOCl or O2
·-
. Some reactive oxidants will react with 
DCFH rapidly and almost immediately increase the DCF formation, while others need more 
time or higher concentrations to increase the formation of DCF (LeBel et al. 1992; Myhre et 
al. 2003). 
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1.6 Aim of study 
The Syrian hamster embryo cell transformation assay has been used for decades as a 
screening system to detect both genotoxic and non-genotoxic compounds with carcinogenic 
potential. It is based on change in morphological growth of cell colonies when exposed to 
carcinogenic compounds, and has a high correspondence with in vivo tests. OECD has 
recently performed a pre-validation study and made a recommended protocol.  
The perfluorinated compounds PFOS, PFOA and PFNA in addition to the brominated flame 
retardant TBBPA have all been proven to cause health effects. It has also been shown that 
they are not mutagenic. PFOS and PFOA have been tested in the SHE CTA, where PFOS 
gave transformation, and PFOA caused increased transformation in conjunction with Benzo-
a-Pyrene (B[a]P). PFNA and TBBPA have not been tested to see if they are carcinogenic 
without being genotoxic. The perfluorinated compounds are found in relatively high 
concentrations in the environment and in humans. 
The main objective of this study was to assess the carcinogenic potential of three different 
compounds, PFOS, PFNA and TBBPA, using the Syrian Hamster Embryo Cell 
Transformation Assay.  
Secondary objectives were to investigate the toxicant’s cytotoxicity and their effects on ROS 
production. The cytotoxicity was tested in the SHE CTA, and ROS production in a DCF 
assay.  
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2. Materials and methods 
2.1 Syrian hamster embryo cell culture 
The cells used in the current experiments were primary cells isolated from 13 days old Syrian 
hamster embryos. Four pregnant Syrian hamsters were ordered from Charles River, USA 
(New England, MA, USA). The isolation was performed according to the “Recommended 
protocol for the Syrian hamster embryo cell transformation assay” (Maire et al. 2012a). The 
mothers were euthanized by the use of CO2 and decapitation. The pups were decapitated 
without the prior use of anesthesia. During the cell harvest the tissue was held on ice at all 
times, and the isolation was executed as sterile as possible. After isolation the cells were 
counted and frozen in vials in liquid nitrogen. This was all done before the experiments 
started. 
 
2.2 Chemicals  
Heptadecafluorooctanedulfonic acid potassium salt (PFOS) (purity ≥ 98.0 %), 
Perfluorooctanoic acid (PFOA) (purity > 96.0 %), Perfluorononanoic acid (PFNA) (purity > 
97.0 %), and 3,3’5,5’-Tetrabromobisphenol A (TBBPA) (purity> 97.0 %) were all purchased 
in powder from Sigma-Aldrich
® 
(St Louis, MO, USA). 
 
2.3 Syrian hamster embryo cell transformation assay 
The chemicals tested and described in this thesis are PFOS, PFNA and TBBPA. The toxicants 
were dissolved in Dimethyl Sulfoxide (DMSO) (Sigma Aldrich®), giving final concentrations 
in the medium from 0.1 nM to 1 mM in the dishes. The stocks were kept in the freezer           
(-20°C) between the experiments.  
Since the toxic solutions were dissolved in DMSO the negative control should contain the 
same concentration of DMSO. The final DMSO concentration in each dish was 0.2 % after 
addition of feeder cells, target cells and exposure to toxicants. Benzo[A]Pyrene (B[a]P) 
(Sigma Aldrich ®), was used as the positive control. B[a]P was as the other toxicants 
dissolved in DMSO. The results were calculated relatively to the negative DMSO control. In 
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addition to dishes with positive and negative controls, there were also two dishes with feeder 
cells in each experiment to ensure that the feeder cells did not divide and form colonies. 
Before the experiment started, medium was prepared and kept in the refrigerator for a few 
weeks. The medium consisted of DMEM powder (GIBCO®, Invitrogen, Paisley, UK) 
dissolved in MilliQ-water (Simplicity Water purification System, Millipore, Billerica, MA, 
USA), 20 % fetal bovine serum (FBS) (batch # 8180923, GIBCO®, Invitrogen), 1.5 g/L 
NaHCO3 (Sigma Aldrich®) to adjust the pH and 2 µg/ml insulin (Sigma Aldrich
®
, stock 
solution 10 mg/ml in sterile water containing 1 % glacial acetic acid). All additives and 
medium were mixed and filtered through a 0.2 µm filter (Millipore) for sterilization.  
Cryopreservation medium was made right before use, and consisted of complete medium 
(described over) and 15 % DMSO. The cryopreservation medium was kept on ice the whole 
time.  
The SHE CTA can be performed at both pH 6.7 and pH 7.0. In the current experiments pH 
7.0 was applied. It is a slight difference in the way the cell colonies grow depending on the 
pH, and therefore a difference in the colonies scored. A protocol using pH 7 was established 
in the laboratory of our collaborator, Edgar Rivedal, and it was therefore chosen to perform 
the current experiments at this pH. The cultivation of the SHE cells was carried out 
aseptically in a laminar air flow cabinet. 
Primary culture of SHE cells were cultivated mainly corresponding to the “Recommended 
protocol for the Syrian hamster embryo cell transformation assay” (Maire et al. 2012a), with a 
few adaptations. On day one and day two respectively, the feeder and target cells were seeded 
onto the dish. On day three the cells were exposed to the toxicants and on day nine the 
medium was changed and the cells re-exposed. On the tenth day the cells were fixated, stained 
and left to air-dry. The procedure is showed step by step in Figure 5. 
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Figure 5: Experimental procedure for the SHE CTA. The first day the feeder cells were 
seeded, the second day the target cells were seeded and on the third day the cells were 
exposed to the toxicants. The medium was changed on day nine, and on the tenth day the cells 
were stained and fixated. 
2.3.1 Development of the method 
There are many parameters affecting the Syrian hamster embryo transformation assay. It is 
variability in how sensitive different SHE cell isolates are to morphological transformation. In 
addition there are differences in FBS lots’ ability to support SHE cell growth and 
transformation (Kerckaert et al. 1996). Additionally the feeder cells can affect how well the 
target cells grow. Preliminary studies were first carried out testing four different batches of 
cell isolates (A, B, C and D) and three different batches of fetal bovine calf serum batch # 
8180923 (GIBCO® Invitrogen), Lot no: A5011-2960 and Lot no: A55111-3462 (Thermo 
Fisher Scientific, Waltham, MA, USA), to find the most sensitive and growth effective 
combination. Cell isolate C and D were the cell isolates, which had the best growth. Batch D 
was chosen over batch C because it had almost 60 vials more of cells. FBS batch # 8180923 
was chosen as it gave a good plating efficiency (PE), and it gave the densest cell colonies. The 
colonies in the two FBS batches from Fisher gave low PE and thin cell colonies. Later on 
another FBS batch from Invitrogen (batch # 1013153) was also tested, but it did not give any 
better results than the first batch from Invitrogen, and it was decided not to change batch. 
Preliminary studies were also carried out to test varying percentages of FBS (10 %, 15 % and 
20 %), varying concentrations of the positive control B[a]P, with and without an extra day of 
exposure, with and without insulin and with and without change of medium on day nine. 
Based on these studies the final medium contained 20 % FBS and insulin and was changed at 
day nine, to get rid of fibronectin, which accumulates in the medium and suppresses 
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transformation (Rivedal 1982). The method development was conducted with guidance from 
Edgar Rivedal at the Oslo University Hospital. 
2.3.2 Preparation of feeder-cells 
The feeder-cells were prepared in advance, and kept frozen in liquid nitrogen until used. 
Frozen vials of cryopreserved SHE cells were thawed rapidly in a 37°C water bath (Grant 
Instruments (Cambridge) Ltd, UK). The cell suspension was added gently to the side of a 100 
mm tissue culture Falcon
TM 
plastic dish (BD Bioscience, Bedford, MA) and mixed drop-wise 
with 15 ml cold medium (DMEM), to dilute the DMSO. The medium was changed with 10 
ml fresh medium after 4-5 hours to remove the DMSO. The cells were then incubated in a cell 
incubator (Thermo Fisher Scientific, HERAcell 150i, CO2 Incubator) with 10 % CO2, 37°C 
and humidified air, for 2-3 days to achieve 50-90 % confluence.  
On the day of irradiation each plate was rinsed twice with 5 ml DPBS-CMF (-Ca
2+
, - Mg
2+
, 
GIBCO®, Invitrogen). After the PBS was removed, 2 ml of detachment solution (0.25 % 
Trypsin, GIBCO®, Invitrogen) was added to the cells. The detachment was observed in a 
light microscope (Leitz Labovert, Michigan, MI, USA) and the activity of the trypsin was 
stopped before the cells looked rounded, and were still a bit comma shaped. The cells were 
removed and added to 30 ml medium in a 50 ml Falcon
TM
 tube (BD bioscience). The 
detachment procedure was repeated twice to get as many cells as possible. The 50 ml tube 
with the cells and the dissociation solution was centrifuged for 10 minutes at 300 xg, to 
remove the trypsin (Heraeus, Multifuge X1R, Thermo Fisher Scientific). The supernatant was 
removed and the pellet resuspended in 5 ml of cold medium and put on ice.  
20 ml of cells were exposed to X-ray irradiation (5000 rads), for 10 minutes, in a Muller X-
ray cabinet at the Oslo University Hospital, so that they were still viable, but no longer 
capable of replication. Viable cells were counted using an automated cell-counter 
(Invitrogen™, Countess ™, automated cell counter), and diluted to 3.3x106 cells/vial in 
cryopreservation medium. They were placed at -80°C in a Styrofoam-box overnight, and then 
put in liquid nitrogen where they were kept until used. Two dishes with feeder-cells were 
seeded to check their viability and lack of ability to divide.  
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2.3.3 Dose-range finding test 
Before running the SHE CTA a dose-range finding (DRF) test had to be carried out. The DRF 
test was done to decide, which concentrations of the different chemicals should be tested, and 
to decide how many cells should be seeded at the different concentrations. At least ten dishes 
were seeded per concentration tested; the number of target cells seeded corresponded to the 
number giving 25-45 colonies in the DMSO control. The definite doses for the transformation 
assay were based on the DRFs. The transformation experiments should include at least one 
dose, which had no cytotoxic effect, a high dose which caused an approximate 50 % reduction 
in RPE or relative colony size or density, and four concentrations in-between (Maire et al. 
2012a). In the current experiments some lower concentrations were added to get closer to 
real-life exposures. In total 10 different concentrations of each substance were tested. 
The DRF tests were also used to adjust target cell seeding number. An average of 25-45 
colonies per dish should be obtained to consider the assay valid, and the number of target cells 
seeded must be adjusted according to the cytotoxicity of the toxic substances. In this 
experiment the seeding number was adjusted when the RPE was more than than 15 % lower 
than the DMSO control.  
On day one, three vials of x-ray irradiated feeder cells were thawed and transferred into 15 ml 
tubes (BD bioscience) with 10 ml of cold fresh complete medium. The tubes were centrifuged 
at 300 xg for 10 minutes to eliminate DMSO, and the supernatant was removed. The pellets 
were resuspended and pooled from the tubes in 3 ml of medium. The cells were counted using 
an automated cell counter, and 17 000 cells/ml were seeded into 60 mm
2
 plastic dishes (BD 
bioscience) in 3 ml fresh medium. The dishes were set in an incubation cabinet for 24 hours at 
37°C and 10 % CO2. A different batch of feeder-cells was used in the experiments with 
PFOS, than in the experiments with TBBPA and PFNA.  
Also on the first day, one vial of frozen SHE cells, from batch D, was thawed. These cells 
were called target cells. The cells were added to a 25 cm
2
 cell culture flask (BD bioscience) 
and mixed drop-wise with 10 ml of cold medium, to dilute the DMSO. The medium was 
removed and replaced by 5 ml of fresh medium after 4-5 hours. These cells were also left to 
incubate for 24 hours in the humidified cell incubator at 37°C and 10 % CO2.  
At the second day the target cells were seeded onto the dishes with the feeder cells. The 
medium was removed from the 25 cm
2
 cell culture flask and the cells rinsed twice with 2 ml 
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DPBS-CMF. The DPBS-CMF was removed and 2 ml detachment solution (trypsin) was 
added to the flask. The extent of trypsinization was followed in the microscope and the cells 
were transferred to a 15 ml tube with 8 ml of cold medium, before they looked rounded, and 
still a bit comma shaped. The tube was centrifuged for 10 minutes at 300 xg, the supernatant 
removed and the pellet resuspended in 1.5 ml medium. The cells were counted using an 
automated cell counter, and seeded onto the 60 mm
2
 plastic dishes in a concentration of 35 
cells/ml in 3 ml medium. The cells were left to incubate for 24 hours in the incubator cabinet 
at 37°C 10 % CO2. 
On day three the cells were exposed to the toxicants. 2 ml of fresh medium was added to the 
dishes with 16 µl of the concentration of the toxicants, giving 2 µl/ml in the final solution of 8 
ml. The dishes were then incubated for six more days at 37°C and 10 % CO2. 
The ninth day the medium was changed and the cells re-exposed. The medium was removed 
and replaced with 8 ml fresh complete medium with 2 µl/ml of each of the concentrations of 
the toxicants. Then the cells were incubated for another 24 hours. 
On the tenth day the cells were fixed and stained. The fixation of the cells was done in a fume 
hood. The medium was aspirated and the dishes washed with 5 ml PBS (37°C). The PBS was 
then removed and the cells fixated with 5 ml 90 % ethanol (Kemetyl, Halden, Norway). After 
10 minutes the ethanol was removed and the dish left to air-dry. Finally the cells were stained 
with 10 % Giemsa ((Sigma Aldrich®) mixed with distilled water) for 20 minutes, before the 
Giemsa was removed and the dishes were washed in running tap water. The dishes were then 
left to air-dry. 
The colonies were counted in a stereomicroscope to decide the number of cells that had to be 
seeded to get about 35 colonies per dish in the following transformation assay, and to decide 
which concentrations should be used. The cytotoxicity of the compounds is shown by colony 
density, size and RPE (relative plating efficiency). 
2.3.4 Transformation assay 
The transformation assay was carried out as described above in the DRF test. In total 40 
dishes were seeded per concentration over three different experiments. The number of cells 
seeded for each concentration was adjusted after the DRF test. For PFOS the concentrations 
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tested were between 0.1 nM and 250 µM. For PFNA the concentrations tested were between 
10 nM and 550 µM, and for TBBPA the concentrations ranged between 0.1 nM and 185 µM. 
The colonies were examined under a stereomicroscope for the scoring of transformed 
colonies. An example of normal and transformed colonies is displayed in Figure 6. 
 
Figure 6: Pictures of two Syrian hamster embryo cell colonies. To the left a transformed cell 
colony where the cells grow over the feeder cells, have a low cytoplasm to nucleus ratio and 
grow in criss-cross. To the right a normal cell colony where the cells are avoiding the feeder 
cells, have a high cytoplasm to nucleus ratio and grow in a pattern. Scale-bars equal 
approximately 175 µm. 4X magnification (Nikon ECLIPSE TS100, Tokyo, Japan). 
The scoring was performed blindly by two different persons. The photo catalogue for pH 7 
was used as a guide (Maire et al. 2012b).  
To evaluate the results from the SHE CTA several criteria have to be fulfilled. There have to 
be about thousand colonies of each concentration to make the test statistical significant and to 
determine the PE, RPE and MTF (morphological transformation frequency). The colony 
number in each dish has to be between 25-45 colonies, less than 25 giving false positive 
results, and above 45 giving false negative results. A colony has to have at least 50 cells to be 
counted. In addition is it required that the positive control B[a]P has a MTF over 0.6 % and 
that the negative control DMSO has a MTF lower than 0.6 %. 
 
2.4 Detection of reactive oxygen species using the DCF assay 
The DCF assay was used to investigate a potential increase in ROS production. The cells were 
exposed to triplicates of PFOS, PFOA and PFNA at concentrations ranging from 1 µM to 1 
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mM. The TBBPA was tested at concentrations ranging from 10 nM to 1 mM. Stock solutions 
of PFOS, PFOA, PFNA and TBBPA were prepared by dissolution in DMSO. The probe 
DCFH-DA was dissolved in methanol (Merck, Darmstadt, Germany). 
The final DMSO concentration in each well should be 0.2 % after addition of cells, buffer and 
toxicants. DMSO is an antioxidant (Sanmartin-Suarez et al. 2011). It is therefore possible that 
it can decrease basal ROS levels in un-stimulated cells. DMSO controls with the same 
concentration of DMSO as in the experimental wells (0.2 %) were included in at least four 
different sites of the plate. This was done to correct for the suppressive effect of DMSO on 
ROS production. The subsequent calculation of relative fluorescence values were calculated 
as a percentage of the DMSO control. The perfluorinated compounds were tested together on 
one plate for comparison. The testing of TBBPA was done separately. 
Before the experiments started Hank’s Balanced Salt solution (HBSS) buffer (Gibco ® 
Invitrogen) was mixed. To make the 1X HBSS, 50 ml refrigerated HBSS (10X) was added to 
450 ml of distilled water. 175 mg of NaHCO3 was also added before the solution was sterile-
filtered. The solution was kept refrigerated until the day of the experiment. At the day of cell-
exposure 48.5 ml HBSS buffer was supplemented with 1 ml 1M Hepes buffer solution (Gibco 
® Invitrogen) and 0.5 ml 0.5 M glucose (BDH, Poole, UK, dissolved in distilled water). 
Before testing the ROS production after exposure to the chemicals each of the substances was 
tested for auto-fluorescence and to see if they would oxidize the probe by themselves. 
Different concentrations of the toxicants were tested in triplicates, with and without cells, in 
combinations with and without the probe. It was tried to both leave the mix of DCF and the 
toxicant on the plate during the reading and to take it off and wash with buffer before the 
reading. The probe was also tested alone both with and without aspirating and washing. All 
the steps from the addition of the DCFH-DA were done in the dark, since DCFH-DA is 
sensitive to light. 
The Syrian embryo hamster cells used in the DCF experiments were from the same cell 
isolate as the one used in the SHE CTA (cell isolate D). 
2.4.1 Method development of the DCF assay 
Different concentrations of the probe; DCFH-DA (GIBCO ® Invitrogen), were tested, 
ranging from 10 µM to 100 µM, and it was decided to use a final concentration of 10 µM this 
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being the lowest concentration tested with a good effect. Different concentrations of the cells 
were also tested ranging from 10 000 cells/well to 30 000 cells/well. It was decided to use 
25 000 cells per well, since this was the lowest concentration were the cells were confluent 
after 24 hours, giving the most equal amount of cells in each well and thus a consistent 
number of cells producing ROS. Two different positive controls were tested, H2O2 (Norsk 
Medisinal Depot, Oslo, Norway) and12-O-tetradecanoyl-phorbol-13-acetat (TPA) (Sigma-
Aldrich®). H2O2 exposure resulted in between 150 % and 200 % increase in fluorescence 
relative to the DMSO control, while TPA gave a very small increase (Figure 13), and it was 
decided to use H2O2 as a positive control. Since the toxicants were dissolved in DMSO this 
was used as a negative control. In the tests there were also a blank well without cells or 
DCFH-DA to see if the buffer would auto-fluoresce and to remove any background noise. In 
addition a control well with cells and DCFH-DA, which was not exposed was added to the 
plate. Incubation from 15 minutes to 1 hour was tested, and it was decided to incubate for 30 
minutes. 
2.4.2 Measurement of ROS production after exposure to toxic chemicals 
The assessment of ROS by the DCF assay was carried out mainly as described in Myhre et al 
(2009) and Reistad et al. (2005), with some modifications. The cells were thawed and seeded 
as described in the feeder cell preparation above, and then left to incubate for 2 days at 37°C 
and 10 % CO2. On day three the cells were trypsinized, centrifuged and counted as described 
earlier. Then 250 µl medium with 100 000 cells/ml was added to each well in a 96 well 
optical black plate with transparent bottom and lid (Perkin Elmer, Waltham, MA), except for 
the blank were no cells were added. The cells were then incubated for 24 hours at 37°C and 
10 % CO2. After 24 hours the medium was removed and 250 µl HBSS buffer with 10 µM 
DCF was added to all the wells, except the blank, the plate were then incubated at 37°C. After 
30 minutes the HBSS buffer with DCF was aspirated and the wells washed with 250 µl HBSS 
buffer. After removal of the buffer, 250 µl of HBSS buffer with the right concentration of 
toxicants was added to the wells. The concentrations tested were 1 mM, 500, 400, 300, 200, 
100, 10 and 1 µM for the perfluorinated compounds, and 1 mM, 500, 250, 225, 200, 175, 150, 
125, 100, 75, 50, 10 and 1 µM, 100, 10, 1 and 0.1 nM for TBBPA. The wells with the blank 
and the control cells were only added HBSS buffer. DCF fluorescence was subsequently 
measured every third minute for 180 minutes, giving 61 readings, in a microplate 
spectrofluorometer (Wallac VICTOR
3
TM multilabel Counter, Perkin Elmer), at 37°C. The 
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energy of the lamp was set on full (65535), except for the TBBPA readings were it was set to 
50000. The emission was too high to be detected when the lamp was on full energy after 
exposure to TBBPA. The lamp let out waves at 485 nm, and the emission filter picked up 
waves at 535 nm. 
 
2.5 Calculations and statistical analysis 
The statistical analyses were performed in Microsoft Excel 2010, GraphPad Prism 5 and R 
(64 bit). P-values less than 0.05 were considered significant.  
In accordance with the recommended protocol, a one-sided Fisher’s exact-test was used to 
evaluate the transformation results from the SHE CTA in R. This is a pairwise comparison of 
MTF relative to the vehicle control (DMSO control). A Chi-square test was also executed in 
GraphPad Prism 5 giving the same results (results not shown). Data from all three 
experiments were pooled for each concentration tested for analysis of treatment related effect 
(Custer et al. 2000a; LeBoeuf et al. 1996). 
 If only one concentration of the test substance shows a statistically significant response (p < 
0.05), the Cochran-Armitage trend test for a positive dose-related response needs to be 
executed (Custer et al. 2000b; Maire et al. 2012a). 
If the test substance did not get a statistically significant difference from the DMSO control, 
or got a MTF lower than 0.6 % it was considered non-transforming in the SHE CTA assay. A 
test substance was considered positive if an increase in MTF above 0.6 % was observed for at 
least two dose levels and were significantly different from the DMSO control or if a 
significant increase in MTF (above 0.6 %) was observed at a single dose level only, but with a 
general positive trend (Maire et al. 2012a). 
PE, RPE and MTF were determined for all concentrations and controls as described below:  
PE = (total amount of cells seeded/total number of colonies) * 100 
RPE = (PE/PE of DMSO control) * 100 
MTF = (total number of transformed colonies/RPE) * 100 
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The Wallac 1420 manager calculates the integral of the area under the curve (AUC) by the 
trapezium method. To evaluate the ROS production a One-way ANOVA test was used. The 
statistical analysis of the ROS production was made using the raw data, removing the 
background noise found in the blank. The graphs display the results as percent of the DMSO 
control. For comparison between the mean of the DMSO control and the means of each of the 
different experimental groups that were tested, a Dunnett’s post hoc test was used (Motulsky 
2007). 
GraphPad Prism 5 does not perform the Bartlett’s test in cases where there are fewer than four 
individual experimental values. There were only three individual experimental values in these 
experiments. It was therefore assumed that deviations from normality and homogeneity of 
variances between groups were small (Motulsky 2007). 
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3. Results 
3.1 Syrian hamster embryo cell transformation assay 
3.1.1 Method development 
The pre-validation study testing the SHE CTA with SHE cells exposed to different 
concentrations of B[a]P with and without changing the medium at day nine, showed that 
changing the medium increased the MTF compared too not changing the medium. SHE cells 
exposed to 0.1 µg/ml and 0.5 µg/ml B[a]P with medium change got MTF of 1.89 % and 2.92 
% respectively (Table 1). 
Table 1. Cell transformation results after exposure of SHE cells to B[a]P, testing with and 
without medium change. Morphological transformation frequency (MTF) in %. Negative 
control is 0.2 % DMSO. 
 
The pre-validation study testing the SHE CTA with different adaptions to the FBS and with 
an extra day of growth showed that 20 % FBS and insulin in the medium increased the MTF 
in the SHE cells giving an MTF of 0.83 and 0.85 % respectively. Staining on day 11 gave a 
MTF of 0.46 %. All the tests were executed with a change of medium on day nine (Table 2). 
 
 
 
 
 
Test groups Colonies scored
Chemicals/concentrations All Transformed colonies MTF (%)
0.2 % DMSO 350 0 0
0.1 µg/ml B[a]P 232 0 0
0.1 µg/ml with medium change 264 5 1.89
0.5 µg/ml B[a]P 248 0 0
0.5 µg/ml BaP with medium change 240 7 2.92
1 µg/ml B[a]P 248 1 0.4
Transformed colonies
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Table 2. Cell transformation results after exposure of SHE cells to B[a]P, testing percent of 
FBSs, addition of insulin and one extra day of exposure. All tests were performed with change 
of medium (MC). Morphological transformation frequency is showed in percent. The negative 
control is 0.2 % DMSO.  
 
 
3.1.2 Cytotoxicity/Dose-range finding test 
The cytotoxicity of the investigated compounds was calculated as a decrease in RPE relative 
to the DMSO control, in which the RPE was set to 100 %. Diagrams of the cytotoxicity of the 
compounds are shown in Figure 7-9. 
PFOS 
The dose range test performed to decide, which concentrations should be used, showed that 
the RPE was about 50 % after exposure to 250 µM PFOS (Figure 7). After the DRF test it 
was decided that the concentrations tested should be between 0.1 nM and 250 µM.  
 
Colonies scored
Total Transformed colonies MTF (%)
15 % FBS, MC, DMSO control 516 0 0
15 % FBS, MC, 0.5 µM B[a]P 559 0 0
10 % FBS, MC, DMSO control 408 0 0
10 % FBS, MC, 0.5 µM B[a]P 546 0 0
20 % FBS, MC, DMSO control 147 0 0
20 % FBS, MC, 0.5 µM B[a]P 360 3 0.83
15 % FBS, MC, Insulin, DMSO control 126 0 0
15 % FBS, MC, Insulin, 0.5 µM B[a]P 351 3 0.85
15 % FBS, MC, Stain day 11, DMSO control 492 0 0
15 % FBS, MC, Stain day 11, 0.5 µM B[a]P 432 2 0.46
Test groups Transformed colonies
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Figure 7: Relative Plating Efficiency of SHE cells after exposure to PFOS in percent of the 
DMSO control.  
The DRF test was also done to be able to correct for a decrease in PE at the higher 
concentrations, so it was seeded enough cells to give the optimal amount of colonies (25-45). 
After the DRF experiment with PFOS the amount of cells seeded was adapted for the 150, 
200 and 250 µM concentrations, seeding 36, 40 and 53 cells/ml respectively, in contrast to 
seeding 25 cells/ml for the other concentrations.  
PFNA 
The dose range test performed to decide, which concentrations should be used, showed that 
the RPE was about 50 % after exposure to 550 µM PFNA. 
 
Figure 8: Relative Plating Efficiency of SHE cells after exposure to PFNA in percent of the 
DMSO control.  
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Based on the DRF test it was decided that the concentrations to be tested in the transformation 
assay for PFNA should be between 10 nM and 550 µM. The number of cells seeded in the 
exposure concentrations 450, 500 and 550 µM was adjusted, seeding 27, 33 and 41 cells/ml 
respectively, while for the less cytotoxic concentrations 25 cells/ml were seeded. 
 TBBPA 
The dose range test performed to decide, which concentrations should be used, showed that 
after exposure to 185 µM TBBPA the RPE was closest to 50 %. 
 
Figure 9: Relative Plating Efficiency of SHE cells after exposure to TBBPA in percent of the 
DMSO control.  
Based on the DRF test the highest dose included in the transformation experiments was 185 
µM TBBPA, and the lowest was 1 nM. It was decided to seed 35 cells/ml in 185 µM TBBPA, 
compared to 25 cells/ml in 3 ml for the rest of the dishes. 
3.1.3 Transformation assay 
PFOS 
The transformation assay testing PFOSs carcinogenic potential found that none of the 
concentrations tested were significantly different from the negative control DMSO (One-sided 
Fisher exact test p <0.001). Neither did B[a]P get significantly different values compared to the 
DMSO control, with a p-value of 0.097. Neither of the PFOS concentrations tested, nor 5 
µg/ml B[a]P gave a MTF above 0.6 % (Table 3). 
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Table 3. Cell transformation results after exposure of SHE cells to PFOS. Morphological 
transformation frequency (MTF in %), Relative plating efficiency (RPE in %) measured after 
seven days of exposure. Positive control was B[a]P. 
 
PFNA 
The transformation assay investigating PFNA showed that 500 µM PNFA and 5µg/ml B[a]P 
were significantly different from the negative control DMSO with p= 2.2 * 10
-16 
and p= 
0.0031 respectively (One-sided Fisher exact test). The same calculations performed on the 
rest of the concentrations did not give any results significantly different from the DMSO 
control. 500 µM PFNA, 1 µM and 5 µg/ml B[a]P gave MTF over 0.6 % with a MTF of 6.461, 
0.637 and 1.085 % respectively (Table 4). The DMSO control gave a MTF below 0.6 % with 
a MTF of 0.154 % 
Table 4. Cell transformation results after exposure of SHE cells to PFNA. Morphological 
transformation frequency (MTF in %), Relative plating efficiency (RPE in %) measured after 
seven days of exposure (**Significant different from DMSO control; P < 0.001). Positive 
control was B[a]P. 
 
Chemicals Concentration All PE (%) RPE (%) Transformed colonies MTF (%)
PFOS 0.1 nM PFOS: 1530 49 94 2 0.131
1 nM PFOS: 1544 49 95 3 0.194
10 nM PFOS: 1520 48 94 2 0.132
100 nM PFOS: 1534 50 97 3 0.196
1 µM PFOS: 1574 50 97 1 0.064
10 µM PFOS: 1630 52 100 2 0.123
100 µM PFOS: 1581 50 97 1 0.063
150 µM 1564 35 68 1 0.064
200 µM 1459 29 56 1 0.069
250 µM 1465 22 42 1 0.068
BaP 5 µg/ml 1333 43 84 5 0.375
DMSO 0.2% 1624 52 100 1 0.062
Test groups Colonies scored Transformed colonies
Chemicals Concentration All PE (%) RPE (%) Transformed colonies MTF (%)
PFNA 10 nM 1305 45 101 2 0.153
100 nM 1299 44 99 7 0.539
1 µM 1255 43 97 8 0.637
10 µM 1285 44 99 1 0.078
100 µM 1281 44 99 2 0.156
200 µM 1176 40 90 2 0.170
400 µM 1148 39 88 1 0.087
450 µM 1216 38 86 2 0.164
    ** 500 µM 1362 42 95 88 6.461
550 µM 855 18 41 4 0.468
B[a]P  ** 5 µg/ml 1198 41 92 13 1.085
DMSO 0.2 % 1298 44 100 2 0.154
Test groups Colonies scored Transformed colonies
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TBBPA 
The cell transformation assay testing TBBPA found that the concentrations 175 µM TBBPA, 
185 µM TBBPA and 5 µg/ml B[a]P were significantly different from the negative control 
DMSO with p=8.19 x10
12
 , p= 2.2 *10 
-16
 and p= 0.004956, respectively (One-sided Fisher 
exact test). The rest of the concentrations are not significantly different from the DMSO 
control according to the One-sided Fisher Exact test, and the DMSO control gave MTF below 
0.6 % with a MTF of 0.468 (Table 5). 
Table 5. Cell transformation results after exposure of SHE cells to TBBPA. Morphological 
transformation frequency (MTF in %), plating efficiency (PE %) and relative plating 
efficiency (RPE in %) measured after seven days of exposure (** Significant different from 
DMSO control; p < 0.001). Positive control was B[a]P. 
 
175 µM TBBPA, 185 µM TBBPA and 5 µg/ml gave a MTF over 0.6 %. The DMSO control 
gave a MTF below 0.6 %. 
 
 
 
 
 
 
Chemicals Concentration All PE (%) RPE (%) Transformed colonies MTF (%)
TBBPA 0.1 nM 1377 46 107 2 0.145
1 nM 1360 47 109 9 0.662
10 nM 1351 47 109 4 0.296
100 nM 1348 46 107 8 0.593
1 µM 1341 46 106 4 0.298
10 µM 1358 47 109 8 0.589
100 µM 1403 45 105 7 0.499
150 µM 1323 47 110 13 0.983
     ** 175 µM 956 36 83 47 4.916
     ** 185 µM 1393 28 66 98 7.035
B[a]P  ** 5 µg/ml 1215 40 93 20 1.645
DMSO 0.2% 1282 43 100 6 0.468
Transformed coloniesColonies scoredTest groups
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3.2 Detection of ROS production 
3.2.1 Perfluorinated compounds 
In the preliminary studies, it was found that the PFCs did not oxidize the DCFH-DA probe by 
themselves or auto-fluoresce (results not shown).  
None of the three perfluorinated compounds were found to be significantly different from the 
DMSO control when analyzed with a one-way ANOVA and a Dunnett’s post hoc test, 
whereas the positive control H2O2 was found to be significantly different from the DMSO 
control. Average relative fluorescence values for the different perfluorinated compounds are 
presented in Figure 10, 11, and 12.  
 
Figure 10: Relative fluorescence values as a measure for ROS production in SHE cells after 
exposure to PFOS, in percent of DMSO control. The positive control is H2O2. (* Significantly 
different from DMSO control (p < 0.001)). 
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Figure 11: Relative fluorescence as a measure of ROS production in SHE cells after exposure 
to PFOA in percent of the DMSO control. H2O2 is the positive control. (* Significant different 
from DMSO control (p < 0.001)) 
 
Figure 12. Relative fluorescence values as a measure for ROS production in SHE cells after 
exposure to PFNA, in percent of the DMSO control. H2O2 is the positive control. (* 
Significantly different from DMSO control (p < 0.001)) 
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3.2.2 TBBPA 
In the preliminary studies, when testing if TBBPA would auto-fluoresce or oxidize the probe 
by itself, it was found that TBBPA oxidized the probe. It was therefore not possible to detect 
increases in ROS production caused by TBBPA exposure using the DCF assay. The relative 
fluorescence for TBBPA with and without cells is presented in Figure 13. 
 
Figure 13: Relative fluorescence as a measure of ROS production in SHE cells after exposure 
to TBBPA, in percent of the negative DMSO control, testing TBBPA for auto-fluorescence 
and if the toxicant would oxidize the probe DCFH-DA. H2O2 and TPA are positive controls. 
The concentrations of TBBPA tested with the probe DCFH-DA, without cells, that were left 
in the well during the reading gave values around 300 and 400 in percent of the negative 
control DMSO. It was about the same values as for the same concentration with cells. 
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4. Discussion 
4.1 Syrian hamster embryo cell transformation assay 
About 40 % of the chemicals which have been found to induce tumors in long-term animal 
experiments are devoid of gene mutation activity (Rivedal & Haddeland 1996; Tennant & 
Ashby 1991). It is therefore necessary to have methods detecting carcinogens which are not 
genotoxic in addition to the ones that are genotoxic. The SHE CTA is one of few in vitro 
assays which detect both genotoxic and non-genotoxic carcinogens (Adler et al. 2011). 
4.1.1 Method development 
There are a lot of factors influencing the capacity of SHE cells to transform. Different SHE 
cell isolates have different variability in sensitivity to morphological transformation. FBSs 
have different ability to support cell growth and transformation. In addition the feeder cells 
differ in their ability to support growth of target cells (Kerckaert et al. 1996). In the present 
study it was experienced that a change of feeder cell batch reduced PE in the PFNA and the 
TBBPA experiments as compared to the batch used in the PFOS experiments, it is also 
possible that it affected the transformation rate in the PFOS experiments.  
The SHE cell isolates are from different hamsters and have different variability in sensitivity 
to morphological transformation. The FBS can contain different amounts of factors affecting 
the SHE cells growth and transformation. Three different FBS-lots were therefore tested and 
batch # 8180923 from Invitrogen was chosen as it gave the highest PE and the densest cell 
colonies. Another batch from Invitrogen was tested later on, but it did not give better results 
than the first batch, and it was decided not to change. Different percentages of the chosen FBS 
were also tested, 20 % FBS gave the best result in this experiment (Table 2).  
Rivedal and Haddeland (1996) tested the role of serum in the SHE CTA, trying to 
characterize and partially purify protein factors in FBS. They found that one of the factors 
affecting the FBSs ability to support transformation is the amount of fibronectin in the 
medium (Rivedal & Haddeland 1996).The disorganized growth pattern of transformed cells 
has been shown to be restored after exposure to fibronectin (Rivedal 1982). To optimize the 
protocol in the present study it was decided to change medium on day nine to remove 
fibronectin, giving the cells a day with less inhibition. This was shown to be effective, giving 
a higher rate of transformation (Table 1). 
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On the background of preliminary tests it was chosen to add insulin to the medium to get 
thicker and more compact cell colonies. Insulin is an important growth factor, and it is 
thought to promote tumor development (Argiles & Lopez-Soriano 2001; Boyd 2003). The 
addition of insulin gave denser colonies, in addition to an increase in morphological 
transformation (Table 2). 
Together these adjustments on FBS, insulin and medium change optimized the assay, giving 
the wanted type of colonies and a higher frequency of morphological transformation, than 
without the adaptions. 
4.1.2 Cytotoxicity/Dose-range finding test 
Based on the present study TBBPA reduces RPE to 50 % on lower concentrations than the 
perfluorinated compounds; 185 µM getting closest to 50 % (Figure 9). PFOS halved the RPE 
with the lowest concentration of the perfluorinated compounds in these experiments; around 
250 µM (Figure 7). PFNA needed the highest concentration to get a 50 % reduction in RPE; 
around 550 µM (Figure 8). It was not performed any cytotoxicity test on PFOA, since it was 
not tested in the SHE CTA in the current study. PFOA usually needs a higher concentration 
than PFOS to get a 50 % reduction in PE, such as in the experiments done by Florentine et al. 
(2011). In the SHE CTA experiments executed by Jacquet et al. (2012), the 50 % reduction in 
RPE was achieved between 300 µM and 370 µM. 
In the transformation experiment at least one high concentration should be included, giving 
approximately 50 % reduction in RPE. The concentrations tested in the experiments were 
based on the DRF test. Several experiments were required to find a concentration giving a 50 
% reduction in RPE after exposure to TBBPA. The cytotoxicity changed slightly between the 
experiments, and a few extra concentrations were tested in later experiments to get closer to a 
50 % reduction in RPE, giving a less accurate number than if all the concentrations were 
tested in one experiment. In addition it is a small range were TBBPA changed from  not 
reducing RPE to killing almost all the colonies.  
Even though concentrations lower than the one not giving an effect on RPE was added to get 
closer to real life exposure concentrations, these concentrations are higher than the 
concentrations found in human serum. It is however important to pay attention to the 
uncertainties related to the extrapolation of effective doses in vitro to effective concentration 
in humans. Real life exposures in cell models are not really real life exposures, even though 
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the concentrations are the same. There are factors in the body in vitro studies cannot imitate. 
In addition the tests performed in this study only exposed for seven days, while in real life we 
are exposed to these toxicants on an everyday basis our entire life. 
Although the SHE CTA is an in vitro method and the results cannot be directly extrapolated 
to in vivo studies, it can however give an indication of which chemicals should be further 
investigated. As earlier mentioned the SHE CTA corresponds 85 % to a two year rodent assay 
(Kamendulis et al. 2002). 
4.1.3 Transformation assay 
Accurate scoring of the colonies can be difficult and it is critical that this is executed 
correctly. It could be a certain degree of subjectivity in the scoring of each colony, and it is 
therefore vital that two people perform the scoring. It is also important that those doing the 
scoring go through some training, and use the photo catalogue as a guide. The scoring must be 
done blindly; the dishes are therefore coded before the scoring begins. Both within-laboratory 
and between laboratory reproducibility were assessed in the, European Union Reference 
Laboratory for alternatives to animal testing (EURL ECVAM), pre-validation study 
(Vanparys et al. 2011). The study demonstrated that within-laboratory and between 
laboratories reproducibility were satisfactory for the SHE CTA. It was also considered to be 
satisfactory transferable between laboratories (Corvi et al. 2012).  
PFOS 
Exposure to PFOS did not give a statistically significant transformation rate in SHE cells in 
the current experiment. The positive control B[a]P did not get a MTF above 0.6 % and was 
therefore not significantly different from the DMSO control. The test is therefore not valid 
(Table 3). It is not possible to decide if PFOS causes transformation in SHE cells based on the 
present experiment.  
Jacquet et al. (2012) have tested the carcinogenic potency of PFOS using the SHE CTA. They 
found that it caused transformation in cells when using the concentrations 3.7 and 0.37 µM 
giving a MTF of respectively 1.10 and 0.97 %. 
PFOS is the perfluorinated compound found in highest concentration in the Norwegian 
population. It has been detected a concentration of 32 ng/ml in serum (Haug et al. 2010). In 
2000-2001 concentrations between 800-950 µM PFOS were found in serum from 
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occupationally exposed workers in the USA. This is a very high number. Luckily the 
concentration has been reduced since 1995, and is hopefully still decreasing (Fromme et al. 
2009). This shows that banning the production of a compound helps reduce its amount in the 
environment even though it is persistent.  
Biological factors are important in this assay. The adaptions made to the protocol in the 
present study were carried out to make the assay as sensitive as possible. Still there were no 
significant results observed in the SHE cells after exposure to PFOS or B[a]P in the three 
studies performed. A difference in the feeder cell batch is a possible reason why this 
experiment did not get valid results, while the other two got high enough MTFs after B[a]P 
exposure. The change in feeder cell batch affected the PE, and it is possible that the second 
feeder cell batch in addition made the assay more sensitive to transformation. 
PFNA 
Exposure to PFNA led to a statistically significantly transformation rate in SHE cells for one 
of the concentrations. There have to be a significant difference from DMSO in two different 
concentrations for the assay to be considered positive, and these results are therefore 
inconclusive. 
The one-sided Fisher exact test confirmed that 500 µM PFNA was significantly different from 
the negative control DMSO. The positive control B[a]P also got statistically significant values 
compared to the DMSO control. Exposure to 1 µM PFNA gave a MTF over 0.6 % (Table 4), 
but the p-value was 0.06, above the limit of p < 0.05. All the dishes with 500 µM PFNA was 
exposed in the same experiment. This makes the results slightly uncertain, even though the 
rest of the results from that experiment do not differ much from the two other experiments.  
Since only one concentration of PFNA was significantly different from the DMSO control a 
Cochran-Armitage trend test had to be performed. It did not detect a positive trend in the 
results after exposure of SHE cells to PFNA, and it is not possible to say if PFNA transform 
SHE cells. 
500 µM PFNA gave 88 transformed colonies (Table 4), while 550 µM gave only four. 550 
µM was the highest concentration tested (Figure 8), and it is possible that a threshold value 
was reached. 550 µM PFNA gave thin colonies which were difficult to score. Some may have 
been excluded because of that. In addition too few colonies were scored at 550 µM (Figure 
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8). It is possible that this is because this concentration was too cytotoxic, and that the 
adjustment number of cells to be seeded was calculated too low. 
There should therefore be performed another experiment on PNFA to clarify the original 
response. It is also possible to execute an experiment testing if PFNA act as a tumor promoter, 
like Jacquet et al. (2012) did with PFOA.  
PFNA is the least investigated compound among the perfluorinated compounds used in this 
study. It is also the perfluorinated compound found at the lowest concentration in human 
serum in Norway, with a concentration of 1.1 ng/ml (Haug et al. 2010). People working with 
ski waxing are more exposed to PFNA than the rest of the population. A study testing a few 
professional ski waxers after the ski-season found that the median of the concentrations in the 
exposed group was 13 ng/ml (Freberg et al. 2010). This is more than ten times higher than the 
average concentration found in human serum in Norway. 
PFNA is the perfluorinated compound, which increases the most in production among the 
PFCs investigated in the current study, since there already are restrictions on the use of the 
other two (Lau et al. 2007). Klif (Klima- og forurensningsdirektoratet) wants to increase the 
knowledge of PNFA and potential health risks associated with it. They have requested that 
more tests are executed to detect possible health effects, in case something should be done to 
reduce the amount of PFNA produced (Stefan et al. 2009). The results in this study shows that 
further studies should be performed to clarify the question about its carcinogenic potential. 
The concentrations tested in present thesis were higher than what found in occupationally 
exposed workers, and the concentration giving significantly results is one of the highest 
tested. It is still within the limits of the test, which are set to 5 mg/ml or 10 mM, whichever is 
the lowest.  
TBBPA 
Exposure to TBBPA led to a statistically significant transformation frequency of the SHE 
cells in these experiments. TBBPA has not earlier been shown to be mutagenic (Darnerud 
2003). The current experiment gives an indication that the carcinogenic potential of TBBPA 
should be further investigated. 
The one-sided Fisher Exact test confirmed that both 175 and 185 µM TBBPA gave 
statistically significant results. The B[a]P was also significantly different from the DMSO 
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control. 150 µM TBBPA and 1 nM TBBPA had a MTF over 0.6 %, but they were not 
significantly different from the DMSO control, and are therefore not considered transformed. 
The rest of the concentrations gave a MTF lower than 0.6 %, had a high p-value, and were 
therefore not significantly different from the DMSO control. The transformation ratio was 
dose dependent, and the transformation frequency was only significant for the highest 
concentrations, which were cytotoxic (Table 5, Figure 9). 
Since two concentrations were significantly different from the DMSO control and had a MTF 
over 0.6 %, in addition to the B[a]P giving a MTF above 0.6 %, this test was positive, and it is 
possible to say that TBBPA causes transformation in SHE cells in this study. Even though the 
concentrations giving transformation are high, they are much lower than the limit for this test, 
which as earlier mentioned, lies on 10 mM or 5 mg/ml, whichever is the lowest.  
TBBPA is one of the most used BFRs. In a dismantling area for recycling of electronics, a 
concentration of 30 ng/m
3
 TBBPA was found in the indoor air. Studies have also found 
presence of TBBPA in serum from workers in electronic recycling (Sjodin et al. 2003). Even 
though TBBPA has a half-life of only 2 days, the exposure may for some workers be constant 
if they inhale the contaminated air every day. The concentrations giving transformation in this 
assay was much higher than the concentrations these workers could get in their blood. But 
they are exposed for a much longer time than seven days.  
 
4.2 Detection of ROS production 
In the present study it was not found a significant increase in ROS production after exposure 
to PFOS, PFOA or PNFA (Figure 10, 11 and 12). A previous study has shown that PFOS can 
increase ROS production by 1.25 fold and PFOA by 1.52 fold compared to unexposed cells, 
in a HepG2 cell line (Eriksen et al. 2010), while a study conducted by Florentin et al. (2011) 
found exposure by PFOS and PFOA to decrease ROS production in the same cell line. Both 
used the DCF assay to detect the ROS production. Eriksen et al. (2010) detected that PFNA 
exposure increased ROS production insignificantly, except after exposure to concentrations of 
1 and 2 mM where the ROS production decreased. The absence of increased ROS production 
in these experiments makes it likely that it can be assumed that increased production of ROS 
is not the mechanism behind these perfluorinated compounds possible carcinogenic potential. 
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This support the assumption by Jacquet et al. (2012) saying ROS production is probably not 
the reason why PFOA causes transformation. 
ROS production after exposure to TBBPA was not possible to measure with the method used 
in this study. TBBPA oxidized the probe by itself, even when there were no cells in the well. 
An increase between three and four fold was shown when TBBPA and DCFH-DA was left 
together in the well during the reading. Some of the concentrations of TBBPA with cells gave 
between four and five fold increases in ROS production in this experiment (Figure 13). Based 
on this experiment it cannot be said if ROS production is one of the mechanisms behind 
TBBPAs carcinogenic potential or not. TBBPA was found to give a concentration dependent 
increase in ROS production in cerebellar granule cells and in human neutrophil granulocytes 
(Reistad et al. 2005; Reistad et al. 2007). Reistad et al. (2005) also used the DCF assay, but 
the article does not say if they tested the compound for auto-fluoresce or to see if it oxidized 
the probe by itself. 
It is possible that TBBPA increases ROS production, but it cannot be investigated using this 
assay. Perhaps an assay where the reduction of antioxidants is investigated could be used as 
an alternative method to examine TBBPAs potential to increase ROS production. 
Even though I did not get any positive results from these experiments the positive control 
H2O2 showed that the assay worked, being the only exposure giving significant results. 
One uncertainty to the accuracy of this assay is the constancy of the amount of cells in the 
wells. It was chosen to seed enough cells to get it confluent after 24 hours getting as close to 
similar conditions in each well at each experiment as possible. Unequal amount of cells can 
give a difference in fluorescence as a measure for ROS production, if fewer cells produce 
ROS.  
In these experiments cells are exposed to single compounds. In real life humans are exposed 
to a mix of compounds, which may have both synergetic and antagonistic effects. It is 
therefore not possible to know how these compounds affect the body in real life based on 
these tests. It can however give an indication on what is interesting to investigate further. 
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4.3 Conclusion 
This study was carried out to investigate the carcinogenic potential to PFOS, PFNA and 
TBBPA using the Syrian hamster embryo cell transformation assay. The results presented in 
this study show that the PFOS test did not give valid results because the morphological 
transformation after exposure to PFOS was too low. It is therefore not possible to say 
anything about the carcinogenic potential of PFOS. The results gave an indication of the 
carcinogenic potential of PNFA, but the results were inconclusive, and it should be performed 
a follow up experiment to clarify the answer presented in this study. TBBPA was shown to 
cause transformation in SHE cells with two concentrations significantly different from the 
DMSO control.  
One of the secondary objectives was to investigate the cytotoxicity of the same three 
compounds. The results showed that TBBPA needed the lowest concentration to reduce the 
relative plating efficiency to 50 %, with a concentration of 185 µM getting the closest. 250 
µM PFOS was required to do the same and 550 µM of PFNA. TBBPA had a narrow range 
were the cytotoxicity affected the PE, until that point was reached the size and density of the 
colonies were the only endpoints affected. 
The last thing investigated in this thesis was the ability of PFOS, PFNA, PFOA and TBBPA 
to increase production of ROS in SHE cells. This was tested using the DCF assay. Based on 
the results presented in this study none of the perfluorinated compounds increased production 
of ROS in SHE cells. It was not possible to investigate if TBBPA increased ROS production 
because it oxidized the probe, and that made it impossible to know if the increase was because 
of ROS in the cells or if only the TBBPA oxidized the probe. 
 
4.4 Future perspectives 
Considering that PFNA did not give a clear answer it should be performed a follow up 
experiment to clarify the answer found in this study. It would also be interesting to test if it 
acts as a tumor promoter in a two stage transformation assay like PFOA did.  
Further, non-genotoxic mechanisms could be investigated, since none of the compounds 
investigated in present study have proven to be genotoxic. Increase in ROS production is 
probably not a part of the mechanisms of the carcinogenic potential of the perfluorinated 
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compounds. It can however not be ruled out as a part of the mechanism when it comes to 
TBBPA, which oxidized the probe, like the positive control H2O2. 
One possible mechanism that could be investigated is disturbance of gap junctions. When 
looking at the transformed colonies it is obvious that they grow in criss-cross and stacks. 
Normal cells would not grow like that and it is possible they do not “communicate” right with 
each other. Inhibition of gap junction can be a mechanism in cancer.  
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